Reuters: Health
The U.S. Food and Drug Administration approved Biogen Inc and partner Alkermes Plc's oral drug to treat multiple sclerosis, the companies said on Wednesday.
Subscribe to:
Post Comments (Atom)
Popular Posts
|
Popular Posts
|
No comments:
Post a Comment